The University of Arizona
Institutional Knowledge Map (KMap)
Picture of Roberta Brinton

Roberta Brinton

Professor, Evelyn F McKnight Brain Institute | Professor, Neurology | Professor, Neuroscience - GIDP | Director, Center for Innovation in Brain Science | Professor, Pharmacology | Professor, Psychology | Professor, Pharmacology and Toxicology | Professor, Clinical Translational Sciences | Professor, BIO5 Institute | Member of the Graduate Faculty

Pharmacology
Map Page
60+ Collaborators
$54.5M / $145M Funding
30+ Grants
380+ Publications
10+ Tech/Patents
10+ News

About

Director, Center for Innovation in Brain Science, University of Arizona Health Sciences; Professor of Pharmacology, Neuroscience, and Neurology, University of Arizona School of Medicine

Research Area

alzheimer's disease, alzheimer's, sex differences, aging, neuroscience, allopregnanolone, menopause, genetics, bioenergetics, brain aging, neurodegeneration, brain, hormones, metabolism, dementia, clinical trials, regenerative therapy, inflammation, neurodegenerative diseases, clinical trial, women's health, risk factors, precision medicine, pharmacokinetics, brain health, cognitive impairment, biomarkers, perimenopause, hormone therapy, therapeutic

    Page 1 of 8

    Chart
    Bar chart with 42 bars.
    The chart has 1 X axis displaying Year.
    The chart has 1 Y axis displaying values. Data ranges from 1 to 28.
    End of interactive chart.
    Recent

    Impact of fish oil supplementation on plasma levels of highly unsaturated fatty acid-containing lipid classes and molecular species in American football athletes

    2024
    nutritional supplements, athletic performance, lipid metabolism, omega-3 fatty acids, sports nutrition

    Vivaria housing conditions expose sex differences in brain oxidation, microglial activation, and immune system states in aged hAPOE4 mice

    2024
    neuroscience, aging, immunology, animal behavior, oxidative stress

    Sex-specific associations of serum cortisol with brain biomarkers of Alzheimer’s risk

    2024
    alzheimer's risk, research

    Difficult to Treat Depression: Focus on Approach, Algorithms, and Access

    2024
    depression, treatment, approach, algorithms, access

    In vivo brain estrogen receptor density by neuroendocrine aging and relationships with cognition and symptomatology

    2024
    neuroendocrine aging, cognition, symptomatology

    Asymptomatic carotid artery stenosis is associated with increased Alzheimer rsquo;s disease and non-Alzheimer rsquo;s disease dementia risk

    2024
    neurodegenerative diseases, cardiovascular health, vascular health

    Association between CNS-active drugs and risk of Alzheimer’s and age-related neurodegenerative diseases

    2024
    drug effects, neurodegenerative diseases, alzheimer's, central nervous system

    Predictive metabolic networks reveal sex- and APOE genotype-specific metabolic signatures and drivers for precision medicine in Alzheimer's disease

    2023
    metabolic networks, precision medicine, alzheimer's disease, apoe genotype

    Effects of sex and APOE epsilon;4 genotype on brain mitochondrial high-energy phosphates in midlife individuals at risk for Alzheimer rsquo;s disease: A 31Phosphorus MR spectroscopy study

    2023
    alzheimer's, genetics, brain, mitochondria, sex differences

    In vivo Brain Estrogen Receptor Expression By Neuroendocrine Aging And Relationships With Gray Matter Volume, Bio-Energetics, and Clinical Symptomatology

    2023
    neuroendocrine aging, brain estrogen receptor, gray matter volume, bioenergetics, clinical symptomatology

    Page 1 of 13

    Page 1 of 3

    Page 1 of 3
    Roberta Brinton | KMap Profile - Institutional Knowledge Map (KMap)